Ligand Pharmaceuticals Inc (LGND)

Total Costs & Expenses

$55.10M

Quarterly · Period ending: · USD

LGND logo

LGND Total Costs & Expenses

Latest reported$55.10M
LGND Quarterly Total Costs & Expenses ($7.90M → $55.10M)
High-resolution chart · PNG

LGND total costs & expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Ligand Pharmaceuticals Inc Total Costs & Expenses — Quarterly (USD)
Period endingTotal Costs & Expenses (USD)
55,102,000
34,354,000
39,626,000
60,530,000
39,183,000
81,549,000
52,449,000
48,669,000
60,631,000
27,990,000
31,459,000
29,790,000
28,349,000
29,774,000
14,869,000
46,880,000
41,464,000
34,383,000
59,739,000
49,129,000
38,936,000
50,435,000
58,780,000
38,101,000
34,320,000
29,373,000
37,182,000
29,966,000
29,117,000
29,738,000
26,441,000
22,301,000
19,868,000
19,116,000
22,114,000
16,882,000
14,980,000
19,051,000
18,662,000
15,908,000
14,771,000
14,308,000
9,942,000
8,759,000
13,835,000
11,030,000
12,800,000
11,259,000
9,114,000
10,654,000
8,110,000
9,708,000
7,542,000
7,630,000
9,087,000
7,712,000
7,225,000
6,475,000
8,932,000
6,858,000
8,715,000
6,691,000
8,850,000
23,477,000
9,466,000
10,410,000
13,147,000
27,571,000
12,301,000
17,279,000
13,778,000
11,603,000
10,437,000
16,773,000
13,812,000
14,203,000
15,776,000
29,278,000
29,236,000
51,772,000
59,437,000
188,057,000
49,747,000
46,099,000
52,306,000
52,755,000
48,898,000
53,382,000
51,725,000
46,878,000
46,958,000
39,477,000
38,196,000
35,686,000
32,865,000
32,053,000
28,641,000
27,233,000
25,190,000
23,733,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.